NasdaqCM:SNDLPharmaceuticals
A Look at SNDL (NasdaqCM:SNDL) Valuation After Recent Earnings Show Higher Sales and Slimmer Net Losses
SNDL (NasdaqCM:SNDL) has released its third quarter and nine month earnings for 2025, revealing higher sales and a narrower net loss compared to the same periods last year. These updates are sparking fresh investor interest.
See our latest analysis for SNDL.
SNDL’s share price has been on a rollercoaster this year. After a rally earlier in the quarter, it’s taken a breather with a 27.7% drop over the past month and a 14.4% fall in the last week, despite the latest earnings showing meaningful...